DR.Chip Biotechnology Incorporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 88.93 million compared to TWD 93.35 million a year ago. Revenue was TWD 88.93 million compared to TWD 93.35 million a year ago.

Net loss was TWD 17.2 million compared to TWD 27.1 million a year ago. Basic loss per share from continuing operations was TWD 0.91 compared to TWD 1.43 a year ago. Diluted loss per share from continuing operations was TWD 0.91 compared to TWD 1.43 a year ago.